Nicole Wilski

13PUBLICATIONS
37CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 26, 2025
Pyroptosis Modulates Multiple Immune Cell Populations in Targeted Therapy-Treated Melanoma.

Nicole A Wilski-Cronin, Dan A Erkes, Timothy J Purwin

|Aug 28, 2025
A Dual-Payload Bispecific ADC Improved Potency and Efficacy over Single-Payload Bispecific ADCs.

Nicole A Wilski, Peter Haytko, Zhengxia Zha

|Oct 17, 2023
SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death.

Sheera R Rosenbaum, Signe Caksa, Casey D Stefanski

|Jun 21, 2023
Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant Melanoma.

McKenna Q Glasheen, Signe Caksa, Amelia G Young

|Aug 31, 2022
Raptinal Induces Gasdermin E-Dependent Pyroptosis in Naïve and Therapy-Resistant Melanoma.

Megane Vernon, Nicole A Wilski, Daniel Kotas

|Jun 03, 2022
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma.

Weijia Cai, Mai Q Nguyen, Nicole A Wilski

Pageof 3

Frequent Collaborators

9 joint publications

Andrew E Aplin

5 joint publications

Timothy J Purwin

4 joint publications

Christopher M Snyder

4 joint publications

Signe Caksa